Breast Cancer
Latest News
FDA warns of cancer risk in scar tissue around breast implants
This issue differs from breast implant–associated anaplastic large-cell lymphoma, a known risk among implant recipients.
Latest News
Sex is still a taboo subject for patients with breast cancer
Only one out of four patients considered consulting a sexologist.
From the Journals
Stronger evidence that exercise lowers breast cancer risk
“Increasing physical activity and reducing sedentary time are already recommended for cancer prevention. Our study adds further evidence that such...
From the Journals
Time to pull back on postsurgery radiation in breast cancer?
Prospective Dutch study suggests no harm in de-escalating therapy in cT1-2N1 patients.
Latest News
Tumor-bed radiotherapy boost reduces DCIS recurrence risk
Regardless of the whole breast irradiation fractionation schedule, a 16 Gy tumor-bed boost halved the risk of DCIS recurrence at 5 years.
Feature
‘Flat denial’ can leave breast cancer patients with lasting scars
“I’ll just leave a little extra skin, in case you change your mind.”
Latest News
After cancer, abortion experience highlights post-Roe reality
A 2021 study found the rate of maternal mortality was almost two times higher in states that restricted abortion access compared with those that...
Latest News
Does PREDICT accurately estimate breast cancer survival?
“The discordance between OS estimated by PREDICT and the current real-world OS is expected to be even higher.”
From the Journals
Genetic counseling for cancer often costs patients nothing
Genetic counseling is an important feature of cancer care that can affect treatment decisions and surveillance. But coverage of genetic counseling...
From the Journals
Node-negative triple-negative breast cancer prognosis lies within stromal lymphocytes
Every 10% increase in stromal tumor-infiltrating lymphocytes was associated with a 19% reduction in the risk of death.
Latest News
Hormone therapy didn’t increase recurrence or mortality in women treated for breast cancer
Recurrence was increased with vaginal hormone therapy among those taking aromatase inhibitors.